TP53 and glioblastoma: Other observations included were R175H, R248Q and R337C mutations being the most common missense TP53 mutations in the LEB-GBM cohort, each comprising 3.3% (95% CI: -1.2–7.9; n = 2/60) of the samples (Table 1, S3 and S4 Tables).